BCHE and metabolic dysfunction-associated steatotic liver disease: It is speculated that in patients with NAFLD, the increased availability of NEFAs to the liver may stimulate the production of butyryl‐CoA and butyrylcholine, and that this increase may be associated with elevated BChE activity [28].